These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22878964)
21. Predictive role of heterozygous p.R4810K of Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090 [TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205 [TBL] [Abstract][Full Text] [Related]
23. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis. Ma J; Liu Y; Ma L; Huang S; Li H; You C Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837 [TBL] [Abstract][Full Text] [Related]
24. Renovascular hypertension and Kim JY; Cho H Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276 [TBL] [Abstract][Full Text] [Related]
25. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis. Huang Y; Cheng D; Zhang J; Zhao W J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544 [TBL] [Abstract][Full Text] [Related]
26. A new horizon of moyamoya disease and associated health risks explored through RNF213. Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949 [TBL] [Abstract][Full Text] [Related]
27. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden. Ohara M; Yoshimoto T; Okazaki S; Gon Y; Todo K; Sasaki T; Takasugi J; Ohara N; Ihara M; Mochizuki H J Atheroscler Thromb; 2022 Nov; 29(11):1655-1662. PubMed ID: 34955493 [TBL] [Abstract][Full Text] [Related]
28. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans. Park MG; Shin JH; Lee SW; Park HR; Park KP J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162 [TBL] [Abstract][Full Text] [Related]
29. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects. Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease. Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618 [TBL] [Abstract][Full Text] [Related]
32. Differences in the Genotype Frequency of the RNF213 Variant in Patients with Familial Moyamoya Disease in Kyushu, Japan. Takamatsu Y; Higashimoto K; Maeda T; Kawashima M; Matsuo M; Abe T; Matsushima T; Soejima H Neurol Med Chir (Tokyo); 2017 Nov; 57(11):607-611. PubMed ID: 28931766 [TBL] [Abstract][Full Text] [Related]
33. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report. Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of RNF213 rs112735431 Genetic Polymorphism in Non-Cardioembolic Ischemic Cerebrovascular Disease: A Cross-Sectional Study in Thai Patients. Travanichakul S; Chutinet A; Kijpaisalratana N; Snabboon T; Houngngam N; Suwanwela NC Cerebrovasc Dis Extra; 2024; 14(1):118-124. PubMed ID: 39159618 [TBL] [Abstract][Full Text] [Related]
35. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859 [TBL] [Abstract][Full Text] [Related]
36. Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407 [TBL] [Abstract][Full Text] [Related]
37. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease. Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845 [TBL] [Abstract][Full Text] [Related]
38. Role of the Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381 [TBL] [Abstract][Full Text] [Related]
39. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients. Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123 [TBL] [Abstract][Full Text] [Related]
40. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant. Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]